NorthWest Biotherapeutics Inc (NWBO)

[abeta]

notbrad -

can you point to a link?

I found these which are not to your point

2016
NW Bio Announces Phase II Clinical Trial Program Combining DCVax®-L and Pembrolizumab (Keytruda®) for Colorectal Cancer
https://nwbio.com/nw-bio-announces-phase-ii-clinical-trial-program-combining-dcvax-l-and-pembrolizumab-keytruda-for-colorectal-cancer/
https://www.prnewswire.com/news-releases/nw-bio-announces-phase-ii-clinical-trial-program-combining-dcvax-l-and-pembrolizumab-keytruda-for-colorectal-cancer-300364984.html

2017
Investigators line up Keytruda, cancer vax combo trial in glioblastoma
with Agenus’ cancer vaccine Prophage.
https://www.fiercepharma.com/vaccines/keytruda-paired-cancer-vaccine-glioblastoma

2019
by Dr. C.H. Weaver M.D. 6/2019
Pre-surgery Keytruda Immunotherapy Doubles Survival in Recurrent Glioblastoma
The study found that patients receiving neoadjuvant Keytruda had a
median overall survival of 13.7 months versus 7.5 months for patients
who only received adjuvant (post-surgery) treatment
While this study only included 35 patients
https://news.cancerconnect.com/brain-cancer/pre-surgery-keytruda-immunotherapy-doubles-survival-in-recurrent-glioblastoma-N81n2oPbK0qgtzhuzrkzjQ